225Ac-PD-32766

N/A

Report date: 2025/11/20 16:04:53
NME

Base Information

Drug Name225Ac-PD-32766
Drug Alias Name225Ac-PD-32766
ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncNorthstar Medical Radioisotopes Llc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A